The prognostic value of PD-L1 levels in GC patients with high CD8/FOXP3 and low CD8/PD-L1 were also reported [43], which enlightens the strategy of combining some indicators to predict GC patients’s prognosis. This evidence concerns the gene FOXP3 and gastric cancer.